Dr. Taylor's translational and clinical research program focuses on preventing disorders like schizophrenia and bipolar disorder with psychotic features. He is particularly interested in the roles that oxidative stress and neuroinflammation play in psychosis symptom progression in youth.
Dr. Alexander-Bloch investigates normal brain development and the altered developmental trajectories that lead to mental illness. His multi-disciplinary research integrates brain imaging, genomics and clinical information.
Dr. Gur's combined training in Psychology, Neurology, and Psychiatry enabled her to pursue an academic career working with basic and clinical neuroscientists to advance the understanding mental disorders.
Synapses were firing throughout the conference room in the Colket Translational Research Building as attendees at the 2017 Research Institute Scientific Symposium held May 2 learned about their colleagues' intriguing research endeavors. The four sessions' themes aligned smartly with the Research Institute's strategic planning process and overall mission of the Children's Hospital of Philadelphia.
Research conducted by PolicyLab at The Children’s Hospital of Philadelphia laid the groundwork for new statewide initiatives that aim to reduce the use of psychotropic medications among Pennsylvania children in the foster care system who are enrolled in Medicaid.
Antipsychotics are a powerful class of medications that increasingly have been prescribed to children to treat disruptive behaviors, particularly for those in foster care. The trend is a disturbing one that has the attention of Pennsylvania state officials.